Magpie (FLY)

Magpie Protocol is a decentralized, liquidity aggregation protocol for cross-chain swaps.

Start:

Dec 12, 2023 00:00:00

Ended:

Dec 30, 2023 00:00:00

0 Likes 0 Dislikes

ICO Details

ICO Details
View Details such as General, Token Supply & More
Magpie (FLY) Token Sale Details
Ticker Symbol:

FLY

Token Type:

ECR-20

Category:

Blockchain Service

Rating:

Token Metrics & Distribution
Token Sale Price
Social Media
About Magpie (FLY)

What Is Magpie?

Magpie Protocol is a decentralized, liquidity aggregation protocol for cross-chain swaps. It provides the best deal on any asset, across the top blockchains, all without the need to bridge any assets. The end result is an extremely fast and gas efficient solution to cross-chain swaps.

Magpie Unique Features

Cross-chain arbitrage


Deploy cross-chain arbitrage and market making strategies.


Yield farming
Browse yield farming opportunities and move assets
and yield farm in a few clicks.


Trading/Cross-chain swaps
Move assets across any chain with the best UX in the
space.


Protect your assets
Speed matters. Seize more opportunities and increase
chances to avoid liquidations.

 

Roadmap

Q3 2022

  • August-September
  • Public alpha release
  • Support for 4 chains
  • Extensive Marketing campaign

Q4 2022

  • October-November
  • Public beta release
  • Support for 5+ chains
  • Token launch build up

Q4 2022

  • November-December
  • FLY public sale
  • Token launch

2023

  • Cross-chain yield aggregation
  • Private RFQ market makers
  • Support for Cardano
  • Stable v1.0 release

2024

  • Swing trading AMM pools

Magpie Token Economy

FLY will work as a governance token and liquidity token. The fees will be redistributed amongst liquidity providers, FLY stakers and operation funds.

Token Distribution

TBA

Token Release Schedule

TBA

Partners & Advisors

TBA

Team

TBA

Investors

Magpie is currently backed by ParaFi, Jump Capital, Wormhole, Republic, Big Brain Holdings, Sandeep, Double Peak, MH Ventures, Serafund, Faculty Capital, Stacker Ventures and Medici.

investors